Organ fibrosis, a major pathological manifestation of scleroderma (SSc), is the result of excessive deposition of collagen I and other extracellular matrix (ECM) proteins. Despite the significant progress that has been made towards unraveling the physiological and pathological mechanisms involved in regulation of collagen genes, a full understanding of these processes is still lacking. In particular, very little is currently known about the molecular mechanism responsible for constitutive upregulation of ECM proteins by SSc fibroblasts. Such knowledge is critical for development of suitable targets for therapeutic intervention. During the last funding period we proposed to test the hypothesis that autocrine TGF-B signaling through overexpression of TGFB receptors is at least partially responsible for the SSc phenotype. To test this hypothesis we blocked TGF-B signaling by overexpressing a kinase-deficient TGF-B receptor II (TBRIIdeltaK). Contrary to our expectations, SSc fibroblasts were mainly unresponsive to this treatment with regard to collagen production. On the other hand, this treatment resulted in a significant downregulation of the ECM production in healthy skin fibroblasts. These results led to a revision of our hypothesis and prompted us to investigate alternative mechanisms that may be responsible for the SSc phenotype. To investigate TGF-B independent pathways, we have focused on CTGF (connective tissue growth factor) and IGFBP5 (IGF binding protein 5). The current research proposal is based on our novel observations indicating that CTGF induction of ECM in human fibroblasts is dependent on insulin signaling and that IGFBP5 also stimulates collagen production by fibroblasts. We propose the following Specific Aims to test the hypothesis that interactions between TGF-B, CTGF, and insulin/IGF pathways are involved in the regulation of the SSc phenotype.
In Specific Aim 1 we will continue to examine the role of the components of the TGF-B signaling pathway in the manifestation of the SSc phenotype.
In Specific Aim 2 we will determine the role of the CTGF-mediated pathway in ECM production by SSc fibroblasts. We will delineate the mechanism of CTGF stimulation of the COL1A2 promoter and characterize the components of the insulin/IGF signaling pathway that contribute to CTGF induction of collagen.
In Specific Aim 3 we will determine the mechanism of IGFBP5 stimulation of collagen production by SSc and healthy fibroblasts. We will analyze expression patterns of IGFBPs in SSc and healthy fibroblasts and utilize purified IGFBP proteins and corresponding cDNAs to probe their role in collagen regulation by SSc and healthy fibroblasts.
In Specific Aim 4 we will examine the in vivo expression of the TGF-B receptor subunits, CTGF, and IGF/IGFBPs in SSc skin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
2R01AR044883-05
Application #
6435015
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Gretz, Elizabeth
Project Start
2002-09-15
Project End
2007-05-31
Budget Start
2002-09-15
Budget End
2003-05-31
Support Year
5
Fiscal Year
2002
Total Cost
$274,480
Indirect Cost
Name
Medical University of South Carolina
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Toyama, Tetsuo; Looney, Agnieszka P; Baker, Brendon M et al. (2018) Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis. J Invest Dermatol 138:78-88
Makino, Katsunari; Makino, Tomoko; Stawski, Lukasz et al. (2017) Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis. Arthritis Res Ther 19:134
Yamashita, Takashi; Asano, Yoshihide; Taniguchi, Takashi et al. (2017) Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis. J Invest Dermatol 137:631-640
Makino, Katsunari; Makino, Tomoko; Stawski, Lukasz et al. (2017) Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis. J Invest Dermatol 137:1671-1681
Kartha, Vinay K; Stawski, Lukasz; Han, Rong et al. (2016) PDGFR? Is a Novel Marker of Stromal Activation in Oral Squamous Cell Carcinomas. PLoS One 11:e0154645
Farina, Antonella; Cirone, Mara; York, Michael et al. (2014) Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma. J Invest Dermatol 134:954-964
Stawski, Lukasz; Haines, Paul; Fine, Alan et al. (2014) MMP-12 deficiency attenuates angiotensin II-induced vascular injury, M2 macrophage accumulation, and skin and heart fibrosis. PLoS One 9:e109763
Chan, Edwin S L; Liu, Hailing; Fernandez, Patricia et al. (2013) Adenosine A(2A) receptors promote collagen production by a Fli1- and CTGF-mediated mechanism. Arthritis Res Ther 15:R58
Markiewicz, Margaret; Znoyko, Sergey; Stawski, Lukasz et al. (2013) A role for estrogen receptor-? and estrogen receptor-? in collagen biosynthesis in mouse skin. J Invest Dermatol 133:120-7
Chrobak, Izabela; Lenna, Stefania; Stawski, Lukasz et al. (2013) Interferon-? promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) ?2. J Cell Physiol 228:1774-83

Showing the most recent 10 out of 48 publications